Skip to main content
. 2021 Dec 21;4(12):e2139573. doi: 10.1001/jamanetworkopen.2021.39573

Figure 4. Long-term Responder Fraction (LTRF) and Rate of Long-term Response for the Standard and Experimental Arms.

Figure 4.

In the center, comparison of LTRFs (95% CIs) in the different treatment arms. At right is the estimation of LTRF differences between the trial arms. IPI indicates immune checkpoint inhibitor; PDL1, programmed cell death ligand 1.